Human Genomics
News
06 Jul 2022
Researchers from Osaka University examined how disease severity is evaluated in the context of preimplantation genetic testing for single-gene diseases (PGT-M) by conducting case studies of the regulatory frameworks governing PGT-M in Japan, the United Kingdom, and Western Australia through analysis of relevant policy documents. Results of their study showed that how policies define the standard for disease severity that would justify PGT-M and how decisions are made regarding the eligibility of individual cases have important social and ethical implications.
Events
Sorry, no events coming up for this topic.
Researchers
Sorry, no researchers coming up for this topic.
Giants in history
Sorry, no researchers coming up for this topic.